Form 4: OPKO Health Director Acquires 30,000 Stock Options
SEC Form 4 Filing
Prem A. Lachman, a director of OPKO Health, Inc., reported the acquisition of 30,000 stock options on April 23, 2025.
Summary
- On April 23, 2025, Prem A. Lachman, a director of OPKO Health, Inc., acquired 30,000 stock options.
- The options have an exercise price of $1.47.
- The options become exercisable on April 23, 2026, and expire on April 22, 2035.
- Following the transaction, Lachman directly owns 30,000 derivative securities.
Sentiment
Score: 5
Explanation: The document is a standard regulatory filing detailing the acquisition of stock options by a company director. It doesn't inherently convey positive or negative sentiment.
Industry Context
This filing is a routine disclosure of insider transactions, which are common in publicly traded companies. It provides transparency into the actions of company directors.
Stakeholder Impact
- The acquisition of stock options by a director could be perceived positively by shareholders as it aligns the director's interests with the company's performance.
Key Dates
| Date | Description |
|---|---|
| 04/23/2025 | Date of earliest transaction: Acquisition of stock options. |
| 04/23/2025 | Date of report. |
| 04/23/2026 | Date the stock options become exercisable. |
| 04/22/2035 | Expiration date of the stock options. |
Keywords
OPKO Health, Stock Options, Form 4, Director, Acquisition, Beneficial Ownership, Lachman, OPK
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.